drugset / Trial / NCT07714525

Triamcinolone Nanocapsules After Endoscopic Nasal Surgery

NCT07714525

Phase 2 Recruiting 50 enrolled Deraya University
RandomizedParallel-groupSingle-blindTreatment

Summary

This randomised, single-masked, parallel-group clinical trial will evaluate the efficacy and safety of a topical triamcinolone acetonide-loaded polymeric nanocapsule formulation for postoperative care following endoscopic nasal surgery. Participants will receive either the investigational triamcinolone acetonide-loaded nanocapsule formulation or standard normal saline nasal irrigation. Postoperative nasal healing, inflammation, patient-reported sinonasal symptoms, postoperative complications, and corticosteroid-related adverse effects will be compared between the two groups.

Timeline

Start
2026-05-01
Primary completion
2027-05-01
Completion
2027-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified Topical